Insect Science Becomes Koppert’s Preferred Supplier for Semiochemicals

Executives share insight on what aspects of ag technology they see as having the greatest impact on the growth in biologicals.

Proposals will improve competitiveness by creating clear pathways for innovation, enabling strategic autonomy for farmers, and ensuring a resilient EU single market.

The Brazilian biologicals market has seen significant growth due to its favorable regulatory environment and low barriers to entry.

Executives share insight on what product categories they anticipate will drive the most growth in the next 10 years in biologicals.

AgriThority’s Luke Samuel details what mistakes biological companies do when taking a product to market.

Without biologicals, the goals of the NAP — and the future of IPM — cannot be achieved, warns WBF Chair and Founder Dr. Minshad Ansari.

Renaissance BioScience Co-CEO John Husnik shares insight on the company’s yeast-based RNA-interference biopesticide technology.

At the core of this agreement is a novel biocontrol product, based on the proprietary strain B2017 of Pseudomonas alloputida.

Executives share insight into whether the tremendous market growth in LATAM is scalable for the biologicals industry.